(Q43861066)

English

Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines

scientific article published in February 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Lack of IFN-gamma-mediated induction of the class II transactivator (CIITA) through promoter methylation is predominantly found in developmental tumor cell lines (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Peter J Van den Elsen

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

object named as

Paula Biesta

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Nienke van der Stoep

1

object named as

Nienke van der Stoep

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Edwin Quinten

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

97

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

501-507

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Class II transactivator regulates the expression of multiple genes involved in antigen presentation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

The two novel MHC class II transactivators RFX5 and CIITA both control expression of HLA-DM genes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA)

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Induction of MHC class I expression by the MHC class II transactivator CIITA.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Role of MHC gene products in immune regulation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

CD4+ T cells: specificity and function.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Sequences and factors: a guide to MHC class-II transcription

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

The HLA crossroad in tumor immunology

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-gamma inducible promoter (PIV) of CIITA.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Assembly of functional regulatory complexes on MHC class II promoters in vivo

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Transcription analysis of class II human leukocyte antigen genes from normal and immunodeficient B lymphocytes, using polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

High-efficiency transformation of mammalian cells by plasmid DNA

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Simplified mammalian DNA isolation procedure

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Major histocompatibility complex class I genes in murine fibrosarcoma IC9 are down regulated at the level of the chromatin structure

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Methylation of class II trans-activator promoter IV: a novel mechanism of MHC class II gene control

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

The establishment and maintenance of DNA methylation patterns in mouse somatic cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

DNA methylation: past, present and future directions

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Enhanced H-2 expression and T-cell-dependent rejection after intracerebral transplantation of the murine lymphoma YAC-1

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Lymphocytic infiltration in juvenile thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Prognostic factors of resectable intrahepatic cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Absence of HLA class I and class II antigens as well as beta 2-microglobulin from normal and pathological human spermatozoa

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Induction of class II major histocompatibility complex antigens in murine placenta by 5-azacytidine and interferon-gamma involves different cell populations

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Origin and roles of genomic methylation patterns in male germ cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Analysis of HLA antigens on germ cells in human semen

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1623

21 January 2018

Identifiers

10.1002/IJC.1623

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43861066&oldid=2246622164"